SHIN NIPPON BIOMEDICAL, Apr-Jun (1Q) Ordinary Profit Increases by 51%
2395 SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. 【J-GAAP】
Earnings ReportSHIN NIPPON BIOMEDICAL LABORATORIES, LTD. <2395> [TSE Prime] announced its financial results at noon (11:30) on August 5th. The consolidated ordinary profit for the first quarter of the fiscal year ending March 2026 (April to June) expanded 0.51 billion yen, an increase 50.6% compared to the same period last year. Progress toward the plan for the six months ending September (first half) of 1.18 billion yen was 43.6%, exceeding the five-year average of 39.6%.
In the most recent three-month period, from April to June (1Q), the operating profit/loss margin worsened from -2.6% in the same period last year to -5.2%.
Kabutan News
Actual Performance and Financial Trends
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Progress Rate vs. First Half |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
5,804M | 1,227M | 1,877M | 1,373M | 33.0 | 50.0 | Aug 2, 2023 | J-GAAP |
|
|
5,549M | -145M | 342M | 122M | 2.9 | 18.7 | Aug 6, 2024 | J-GAAP |
|
|
6,477M | -340M | 515M | 260M | 6.3 | 43.6 | Aug 5, 2025 | J-GAAP |
| YoY | +16.7% | -134.5% | +50.6% | +113.1% | +113.3% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
12,508M | 80M | 1,829M | 1,331M | 32.0 | 20 | Nov 6, 2024 | J-GAAP |
|
Guidance
Apr - Sep, 2025
|
14,542M | -97M | 1,180M | -183M | -4.4 | 20 | May 8, 2025 | J-GAAP |
| YoY | +16.3% | － | -35.5% | － | － |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
26,450M | 4,162M | 7,015M | 5,531M | 132.9 | 50 | May 8, 2024 | J-GAAP |
|
|
32,413M | 2,985M | 6,450M | 4,924M | 118.3 | 50 | May 8, 2025 | J-GAAP |
|
Guidance
Mar, 2026
|
33,272M | 3,550M | 5,927M | 3,550M | 85.3 | 50 | May 8, 2025 | J-GAAP |
| YoY | +2.7% | +18.9% | -8.1% | -27.9% | -27.9% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Operating Profit Margin |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
5,549M | -145M | 342M | 122M | 2.9 | -2.6 | Aug 6, 2024 | J-GAAP |
|
|
6,959M | 225M | 1,487M | 1,209M | 29.0 | 3.2 | Nov 6, 2024 | J-GAAP |
|
|
9,727M | 1,813M | 2,309M | 1,874M | 45.0 | 18.6 | Feb 5, 2025 | J-GAAP |
|
|
10,178M | 1,092M | 2,312M | 1,719M | 41.3 | 10.7 | May 8, 2025 | J-GAAP |
|
|
6,477M | -340M | 515M | 260M | 6.3 | -5.2 | Aug 5, 2025 | J-GAAP |
| YoY | +16.7% | -134.5% | +50.6% | +113.1% | +113.3% |
Related Articles
-
Joshin Denki, Apr-Jun (1Q) Ordinary Profit Decreases by 47%
Tue Aug 5, 2025 12:30 pm JST Earnings -
ASANTE, Apr-Jun (1Q) Ordinary Profit Decreases by 38%
Tue Aug 5, 2025 12:30 pm JST Earnings -
Nippon Yusen Kabushiki Kaisha, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 6%
Tue Aug 5, 2025 12:00 pm JST Earnings -
Nissui, Apr-Jun (1Q) Ordinary Profit Decreases by 12%
Tue Aug 5, 2025 12:00 pm JST Earnings -
TAKARA STANDARD, Apr-Jun (1Q) Ordinary Profit Increases by 36%
Tue Aug 5, 2025 12:00 pm JST Earnings -
BANDAI NAMCO, Ordinary Profit Forecast for First Half Revised Upward by 16%
Tue Aug 5, 2025 11:30 am JST Earnings -
TSUMURA CO, Apr-Jun (1Q) Ordinary Profit Decreases by 56%
Tue Aug 5, 2025 11:30 am JST Earnings -
CREATE MEDIC, First Half Ordinary Profit Increases by 52%
Tue Aug 5, 2025 11:30 am JST Earnings -
TEIJIN LIMITED, Apr-Jun (1Q) Net Income Turns to Loss
Tue Aug 5, 2025 11:30 am JST Earnings -
EDION, Apr-Jun (1Q) Ordinary Profit Increases by 35%
Tue Aug 5, 2025 11:30 am JST Earnings